CLINICAL TRIALS PROFILE FOR SOOLANTRA
✉ Email this page to a colleague
All Clinical Trials for SOOLANTRA
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01493947 ↗ | CD5024 1% [Ivermectin 1%] Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study | Completed | Galderma R&D | Phase 3 | 2012-04-01 | Study objectives: - To compare efficacy and safety of Ivermectin 1% cream versus metronidazole 0.75% cream in subjects with papulopustular rosacea after 16-week topical treatment. - And to compare, for subjects initially successfully treated by 16 weeks treatment, Ivermectin 1 % cream versus metronidazole 0.75% cream during a 36-week extension period by assessing, the time of first relapse, the relapse rate, and the number of days free of treatment |
| NCT02616250 ↗ | MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea. | Completed | Galderma | Phase 4 | 2015-12-01 | The main objective of this study is to evaluate the efficacy of Ivermectin 1% cream (IVM) associated with Brimonidine 0.33% gel (Br) compared with the association of their respective vehicles in the treatment of moderate to severe rosacea. |
| NCT02616250 ↗ | MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea. | Completed | Galderma R&D | Phase 4 | 2015-12-01 | The main objective of this study is to evaluate the efficacy of Ivermectin 1% cream (IVM) associated with Brimonidine 0.33% gel (Br) compared with the association of their respective vehicles in the treatment of moderate to severe rosacea. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SOOLANTRA
Condition Name
Clinical Trial Locations for SOOLANTRA
Trials by Country
Clinical Trial Progress for SOOLANTRA
Clinical Trial Phase
Clinical Trial Sponsors for SOOLANTRA
Sponsor Name
